Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Mirabegron Versus Solifenacin in Multiple Sclerosis Patients With Overactive Bladder Symptoms: A Prospective Comparative Nonrandomized StudyUrology 2020 Aug 19;[EPub Ahead of Print], BM Brucker, D Jericevic, T Rude, E Enemchukwu, D Pape, N Rosenblum, ER Charlson, L Zhovtis-Ryerson, J Howard, L Krupp, B Peyronnet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.